5-Methylimidazole-4-carbonitrile

Catalog No.: 
ACBAKG651
CAS No.: 
108257-41-6
Molecular Formula: 
C5H5N3
Molecular Weight: 
107.12
5-Methylimidazole-4-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$85.00In stockInquiry
5g95%$305.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methylimidazole-4-carbonitrile
IUPAC Name5-methyl-1H-imidazole-4-carbonitrile
MDL No.MFCD19219933
Molecular FormulaC5H5N3
Molecular Weight107.12
SMILESCC1=C(N=CN1)C#N
InChI KeyKODWZZOTTOSNLW-UHFFFAOYSA-N
Synonym4-Cyanoimidazole;4-Methyl-5-cyanoimidazole;5-Methyl-1H-imidazole-4-carbonitrile;1H-IMidazole-4-carbonitrile, 5-Methyl-;5-Methylimidazole-4-carbonitrile;4(5)-cyano-5(4)-methylimidazole;1H-Imidazole-5-carbonitrile, 4-methyl-;4-Methyl-1h-imidazole-5-carbonitrile
CAS No.108257-41-6
PubChem CID21793339

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBAKG651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKUCZ175 route compound structure diagram
    ACKUCZ17568282-53-1In Stock
  2. Then
  3. ACBAKG651 route product structure diagram
    ACBAKG651108257-41-6In Stock
Inquiry

2. ACBAKG651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACILQA629 route compound structure diagram
    ACILQA62915813-08-8In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACBAKG651 route product structure diagram
    ACBAKG651108257-41-6In Stock
Inquiry

3. ACBAKG651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBAKG651 route product structure diagram
    ACBAKG651108257-41-6In Stock
Inquiry

Comments (0)